Cargando…
Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing
[Image: see text] With a renewed and growing interest in therapeutic oligonucleotides across the pharmaceutical industry, pressure is increasing on drug developers to take more seriously the sustainability ramifications of this modality. With 12 oligonucleotide drugs reaching the market to date and...
Autores principales: | Andrews, Benjamin I., Antia, Firoz D., Brueggemeier, Shawn B., Diorazio, Louis J., Koenig, Stefan G., Kopach, Michael E., Lee, Heewon, Olbrich, Martin, Watson, Anna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154579/ https://www.ncbi.nlm.nih.gov/pubmed/33253568 http://dx.doi.org/10.1021/acs.joc.0c02291 |
Ejemplares similares
-
Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020) -
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
por: Hammond, Suzan M, et al.
Publicado: (2021) -
Perspectives on the Designation of Oligonucleotide Starting Materials
por: Kiesman, William F., et al.
Publicado: (2021) -
Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
por: Lange, Jenny, et al.
Publicado: (2022) -
Mass customization: opportunities, methods, and challenges for manufacturers
por: Kull, Hans
Publicado: (2015)